Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTekCapital Regulatory News (TEK)

Share Price Information for TekCapital (TEK)

Share Price is delayed by 15 minutes
Get Live Data
5.40    -0.30 (-5.26%)
Bid:
5.30
Ask:
5.50
Spread: 0.20 (3.774%)
Market Cap: £13.89m
TEK Live PriceLast checked at - London Stock Exchange

Intraday TekCapital Share Chart

Guident Update

6 Sep 2023 07:00

RNS Number : 4841L
Tekcapital plc
06 September 2023
 

-----

6 September 2023

 

Tekcapital Plc

("Tekcapital", the "Company" or the "Group")

Portfolio Company Update

Guident ltd forms new subsidiary to commercialise regenerative shock absorbers

 

Tekcapital Plc (AIM: TEK, the UK intellectual property investment group focused on transforming university technologies into valuable products that can improve people's lives, is pleased to announce that Guident ltd has established a new subsidiary to facilitate the commercialisation of their regenerative shock absorbers (RSA). The subsidiary will contain Guident's RSA intellectual capital including patents, licenses, industrial designs, proprietary data, know-how and relevant team members.

 

As previously announced, Guident secured a paid proof of concept agreement with a tier-1 OEM. This collaboration resulted in successful tests and detailed reports for Guident's regenerative shock absorber. Guident's technology enables regenerative shock absorbers with high energy densities that can recover a vehicle's vibration energy, otherwise lost as heat, due to road irregularities, vehicle accelerations, and braking.

 

Harald Braun, CEO & Chairman of Guident commented:

 

"In light of our recent successes in collaboration with various independent test authorities, we are thrilled to announce the integration of RSA technology into a new dedicated subsidiary named ReVive Energy Solutions, ltd. This strategic move allows us to sharpen our focus on a precision-targeted go-to-market strategy for this what we believe is a revolutionary product. Most commercially available electric vehicles have regenerative braking. We believe that in the near future, most commercial electric vehicles will also have regenerative shock absorbers. This could extend the range between charges and provide power to active suspension to improve ride characteristics and comfort. Our commitment to innovation and sustainability drives us forward, and we believe this marks a significant milestone in our mission to reshape the future of EV technology."

 

The Market

The Edison Electric Institute (EEI) Projects 26.4 million electric vehicles will be on U.S. roads in 2030.[1]

According to the International Energy Agency (IEA), worldwide, 350 million electric vehicles are projected to be on the road by 2030.[2]

 

About Guident

Guident commercializes patented technology to enable safer autonomous vehicles and devices by providing industry-leading AV remote monitoring, control, assistance, and passenger support services. To learn more, please visit www.guident.com.

 

About Tekcapital plc

Tekcapital creates value from investing in new, university-developed discoveries that can enhance people's lives and provides a range of technology transfer services to help organisations evaluate and commercialise new technologies. Tekcapital is quoted on the AIM market of the London Stock Exchange (AIM: symbol TEK) and is headquartered in the UK. For more information, please visit www.tekcapital.com.

 

LEI: 213800GOJTOV19FIFZ85

 

Tekcapital owns 100% of the share capital of Guident Ltd. Guident Ltd. owns approximately 91% of Guident Corp., its US subsidiary and 100% of ReVive Energy Solutions, ltd.

For further information, please contact:

Tekcapital Plc 

Via Flagstaff

Clifford M. Gross, Ph.D. 

SP Angel Corporate Finance LLP

Nominated Adviser and Broker

+44 (0) 20 3470 0470 

Richard Morrison/Charlie Bouverat (Corporate Finance)

Abigail Wayne / Rob Rees (Corporate Broking)

Flagstaff Strategic and Investor Communications

+44 (0) 20 7129 1474

Tim Thompson/Andrea Seymour/Fergus Mellon

 

Forward Looking Statements

This press release is for informational purposes only. The information herein does not constitute investment advice nor an offer to invest and may contain statements related to our future business and financial performance and future events or developments involving Guident or Tekcapital that may constitute forward-looking statements. These statements may be identified by words such as "expect," "look forward to," "anticipate" "intend," "plan," "believe," "seek," "estimate," "will," "project" or words of similar meaning. We may also make forward-looking statements in other reports, in presentations, in material delivered to customers, stakeholders and in press releases. In addition, our representatives may from time to time make oral forward-looking statements. Such statements may be based on the current expectations and certain assumptions of Guident' and/or Tekcapital's management. Please note that these are subject to a number of risks, uncertainties and factors, including, but not limited to those described in various disclosures. Should one or more of these risks or uncertainties materialise, or should underlying expectations not occur or assumptions prove incorrect, actual results, performance or achievements of Guident or Tekcapital may vary materially from those described explicitly or implicitly in the relevant forward-looking statement. Neither Guident nor Tekcapital intends, nor assumes any obligation, to update or revise these forward-looking statements in light of developments which differ from those anticipated.


[1] https://www.eei.org/en/news/news/all/eei-projects-26-million-electric-vehicles-will-be-on-us-roads-in-2030#:~:text=Roads%20in%202030-,EEI%20Projects%2026.4%20Million%20Electric%20Vehicles%20Will%20Be%20on%20U.S.,Infrastructure%20Required%20Through%202030%20report.

 

[2] https://www.iea.org/reports/by-2030-evs-represent-more-than-60-of-vehicles-sold-globally-and-require-an-adequate-surge-in-chargers-installed-in-buildings

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAUPUWPBUPWPUA
Date   Source Headline
4th May 20181:45 pmRNSFinal Results
19th Apr 20187:00 amRNSUK Investor Show
1st Mar 20187:00 amRNSUpdate on Lucyd Blockchain Token Generation Event
14th Feb 20187:00 amRNSPrivate Placement for Belluscura to raise US$1.33m
24th Jan 20187:00 amRNSHolding(s) in Company
22nd Jan 20187:00 amRNSUpdate on Lucyd Blockchain Token Generation Event
18th Dec 20174:14 pmRNSHolding(s) in Company
1st Dec 201710:14 amRNSUpdate re. Belluscura IPO
16th Nov 20178:00 amRNSUpdate re. Belluscura IPO
30th Oct 20177:00 amRNSAcquisition of a Patented AI Valet System
28th Sep 20177:00 amRNSPortfolio Company to Raise Funds via a Token Sale
22nd Sep 20177:00 amRNSInvestor Briefing
31st Jul 20177:00 amRNSHalf-year Report
31st May 201711:18 amRNSResult of AGM
31st May 20177:00 amRNSAcquisition of New Gesture Recognition Technology
9th May 20175:13 pmRNSFinal Results
8th May 20179:11 amRNSNotice of AGM
3rd May 20177:00 amRNSPrivate Placement for Belluscura Ltd
2nd May 20179:31 amRNSApp to Search Global University IP
25th Apr 20177:00 amRNSBelluscura acquires Nanotether Discovery Science
20th Mar 20179:11 amRNSHolding(s) in Company
16th Mar 20179:30 amRNSHolding(s) in Company
10th Mar 20179:31 amRNSExercise of Warrants
3rd Mar 20177:00 amRNSBelluscura Launches Passport Medical Device in US
2nd Mar 20177:00 amRNSBelluscura Ltd Launches Slyde in EU
1st Mar 20177:00 amRNSBelluscura Ltd Launches Wire CaddyT In USA
28th Feb 20177:00 amRNSLicense and Development Agreement
15th Feb 20177:00 amRNSAppointment of Joint Broker
2nd Feb 20179:55 amRNSHolding(s) in Company
1st Feb 20175:25 pmRNSHolding(s) in Company
31st Jan 20174:26 pmRNSTotal Voting Rights and Holding in Company
26th Jan 20173:00 pmRNSResults of proposed placing to raise £2.4m
26th Jan 20177:00 amRNSProposed placing
12th Jan 20177:00 amRNSNotice of Allowance for Energy Harvester Patent
4th Jan 20177:00 amRNSSuccessful Production and Testing of µSaltTM
28th Dec 20167:00 amRNSOut-licence & Strategic Alliance with Wecast
9th Nov 20167:00 amRNSDirectorate Change
31st Oct 20167:00 amRNSStrategic Alliance with Bajainnova SAPI de CV
28th Oct 20167:00 amRNSNotice of Allowance for 2nd Crackle-baked Patent
25th Oct 20167:00 amRNSPrivate Placement for Belluscura Ltd
7th Oct 20164:28 pmRNSHolding(s) in Company
15th Sep 20167:00 amRNSAcquisition of Medical Device Licence
31st Aug 20167:00 amRNSHalf-year Report
30th Jun 20167:30 amRNSGrant of Options
17th Jun 20167:00 amRNSPrivate Placement for Belluscura Ltd
6th Jun 201611:44 amRNSAcquisition of salt reduction technology patent
27th May 20162:47 pmRNSResult of AGM
4th May 20167:00 amRNSPosting of Annual Report and Notice of AGM
29th Apr 20167:00 amRNSFinal Results
28th Apr 20167:00 amRNSAcquisition and Total Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.